SANUWAVE Will Host a Conference Call on November 8, 2024 at 8:30 AM (ET) to Present Q3 Financial Results
November 04, 2024 07:30 ET
|
SANUWAVE Health, Inc.
EDEN PRAIRIE, Minn., Nov. 04, 2024 (GLOBE NEWSWIRE) -- SANUWAVE Health, Inc. (the "Company" or "SANUWAVE”) (OTCQB: SNWV), a leading provider of next-generation FDA-approved wound care products, will...
SANUWAVE Health Announces 1-For-375 Reverse Stock Split
October 16, 2024 07:30 ET
|
SANUWAVE Health, Inc.
Common Stock Will Begin Trading on a Split-adjusted Basis on October 18, 2024 EDEN PRAIRIE, Minn., Oct. 16, 2024 (GLOBE NEWSWIRE) -- SANUWAVE Health, Inc. (the “Company” or “SANUWAVE”) (OTCQB:...
SANUWAVE Announces Record Quarterly Revenues: Q2 FY2024 Financial Results
August 13, 2024 06:00 ET
|
SANUWAVE Health, Inc.
Q2 2024 revenues were $7.2 million, up 53% from Q2 2023. This was an all-time quarterly record for the Company. Q2 2024 Gross Margin was 73%, vs 74% in Q2 2023 GAAP Operating Income...
SANUWAVE Will Host a Conference Call on August 13, 2024 at 8:30 AM (ET) to Present Q2 Financial Results
August 07, 2024 18:51 ET
|
SANUWAVE Health, Inc.
EDEN PRAIRIE, MN, Aug. 07, 2024 (GLOBE NEWSWIRE) -- SANUWAVE Health, Inc. (the "Company" or "SANUWAVE”) (OTCQB: SNWV), a leading provider of next-generation FDA-approved wound care products, will...
SANUWAVE Health Announces Preliminary Revenue Results for the First Quarter 2024 (Ended March 31, 2024)
April 10, 2024 08:30 ET
|
SANUWAVE Health, Inc.
SANUWAVE is pleased to announce preliminary revenues of $5.7 million to $5.9 million for the first quarter ended March 31, 2024. This represents the highest Q1 revenues in company history. Q1 2024...
SANUWAVE Announces Record Q4 and FY2023 Revenue
March 22, 2024 06:00 ET
|
SANUWAVE Health, Inc.
Q4 2023 revenues were a record $7.0 million, up 27% from Q4 2022 FY 2023 revenues were a record $20.4 million, up 22% from FY2022 Operating income was $1 million for Q4 2023 compared to an operating...
SANUWAVE Will Host a Conference Call on March 22, 2024 at 8:30 AM (ET) to Present the Q4 and FY2023 Financial Results
March 20, 2024 07:00 ET
|
SANUWAVE Health, Inc.
EDEN PRAIRIE, MN, March 20, 2024 (GLOBE NEWSWIRE) -- via NewMediaWire – SANUWAVE Health, Inc. (the "Company" or "Sanuwave”) (OTCQB: SNWV), a leading provider of next-generation FDA-approved wound...
SANUWAVE Health Reports Stockholder Approval of SEPA Merger at Special Meeting of Stockholders
February 22, 2024 17:00 ET
|
SANUWAVE Health, Inc.
At a special meeting of stockholders on February 21, 2024, SANUWAVE stockholders approved the business combination with SEP Acquisition Corp. by a vote of 798,379,869 “for” and 5,221,765 “against”...
SANUWAVE Announces Q3 2023 Financial Results
November 10, 2023 05:00 ET
|
SANUWAVE Health, Inc.
EDEN PRAIRIE, MN,, Nov. 10, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire – SANUWAVE Health, Inc. (the “Company” or “SANUWAVE”) (OTCQB: SNWV), a leading provider of next-generation FDA-approved wound...
SANUWAVE Announces Q2 2023 Financial Results
August 11, 2023 06:00 ET
|
SANUWAVE Health, Inc.
EDEN PRAIRIE, MN, Aug. 11, 2023 (GLOBE NEWSWIRE) -- SANUWAVE Health, Inc. (the “Company” or “SANUWAVE”) (OTCQB: SNWV), a leading provider of next-generation FDA-approved wound care products, today...